CSIMarket Company Name, Ticker, Competitors, else..
 
Context Therapeutics Inc   (NASDAQ: CNTX)
 

Context Therapeutics Inc's Suppliers Performance

CNTX's Supply Chain



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

 
CNTX Costs vs Sales of Suppliers Growth

• More on CNTX Suppliers






Context Therapeutics Inc's Comment on Supply Chain


The company utilizes contract manufacturers including Lonza Sales AG, Lonza AG (collectively Lonza), and Just-Evotec Biologics, Inc. It holds license agreements with Lonza Sales for CTIM-76 and CT-202, which grant non-exclusive rights to use Lonza's proprietary technology for development, manufacturing, and commercial purposes. Payments to Lonza consist of royalties and annual fees, subject to reductions and expiration conditions. These agreements may be terminated by either party under specified circumstances. The company intends to establish additional framework agreements with third-party manufacturers to supply active pharmaceutical ingredients (API) and drug products on a project basis and recognizes the importance of maintaining redundant supply sources to prevent disruptions.

Context Therapeutics Inc's Comment on Supply Chain


The company utilizes contract manufacturers including Lonza Sales AG, Lonza AG (collectively Lonza), and Just-Evotec Biologics, Inc. It holds license agreements with Lonza Sales for CTIM-76 and CT-202, which grant non-exclusive rights to use Lonza's proprietary technology for development, manufacturing, and commercial purposes. Payments to Lonza consist of royalties and annual fees, subject to reductions and expiration conditions. These agreements may be terminated by either party under specified circumstances. The company intends to establish additional framework agreements with third-party manufacturers to supply active pharmaceutical ingredients (API) and drug products on a project basis and recognizes the importance of maintaining redundant supply sources to prevent disruptions.







CNTX's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Context Therapeutics Inc 35.32 0.00 -37.33 15
SUBTOTAL 0.00 0.00 0.00 -


Sources: Context Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Context Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.